Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa

dc.article.end-page1320en
dc.article.start-page1314en
dc.citation.doi10.1007/S10461-022-03867-3en
dc.contributor.authorFatima Laheren
dc.contributor.authorKennedy Otwombeen
dc.contributor.authorOfentse Mokwenaen
dc.contributor.authorL G Bekkeren
dc.contributor.authorM Allenen
dc.date.accessioned2024-07-23T05:54:27Z
dc.date.available2024-07-23T05:54:27Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1090-7165en
dc.identifier.urihttps://hdl.handle.net/10539/39052
dc.journal.titleUse of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africaen
dc.journal.volume27en
dc.publisherSPRINGER/PLENUM PUBLISHERSen
dc.titleUse of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africaen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
310.23 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client